title: NRAS-mutant melanoma: response to chemotherapy.
authors.forename: Christopher W M
authors.initials: CW
authors.lastname: Soon
authors.forename: Alain P
authors.initials: AP
authors.lastname: Algazi
authors.forename: Edward N
authors.initials: EN
authors.lastname: Cha
authors.forename: Emma M
authors.initials: EM
authors.lastname: Webb
authors.forename: Adil I
authors.initials: AI
authors.lastname: Daud
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D011905:Genes, ras / Q000235:genetics*; D006801:Humans; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000235:genetics*; D009154:Mutation; D016283:Proto-Oncogene Proteins p21(ras); D012878:Skin Neoplasms / Q000188:drug therapy / Q000235:genetics*; D000077204:Temozolomide
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D016283:Proto-Oncogene Proteins p21(ras); D000077204:Temozolomide